PREDICTIVE VALUE OF HOST-SPECIFIC DONOR HELPER T-CELL PRECURSOR FREQUENCY FOR ACUTE GRAFT-VERSUS-HOST DISEASE AND RELAPSE IN HLA-IDENTICAL SIBLINGS RECEIVING ALLOGENEIC BONE MARROW TRANSPLANTATION FOR HEMATOLOG
- 1 October 1997
- journal article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 64 (8) , 1147-1152
- https://doi.org/10.1097/00007890-199710270-00012
Abstract
Acute graft-versus-host disease (aGVHD) is still one of the main causes of morbidity and mortality after allogeneic bone marrow transplantation. Attempts to avoid GVHD are associated with an increased risk of relapse, probably because the graft-versus-leukemia effect is also abrogated. It was recently suggested that a high frequency of host-specific donor helper T cell precursors (HTLp) might be predictive of significant aGVHD(grade≥II). We retrospectively studied the frequency of HTLp by means of simplified limiting-dilution analysis to determine its predictive value for aGVHD and relapse. Pre-bone marrow transplantation, host-specific donor HLTp frequencies were analyzed in 32 patients who had received marrow from HLA-identical siblings for hematological malignancies, in terms of aGVHD and relapse. HTLp frequencies were significantly higher in patients who had aGVHD≥ grade II (n=14) than in those without aGVHD (n=18)(P=0.007). Patients who relapsed (n=13) had significantly lower HTLp frequencies than those who did not relapse (n=19)(P<0.0001). The probabilities of relapse(Kaplan-Meïer method) when the HTLp frequency was higher and lower than 1/200,000 were 0% and 88%, respectively(P<0.0001). The definition of HTLp cut-off values predictive of aGVHD and relapse should contribute to donor selection and could open the way to protocols adapting immunomodulation to the likely risk of aGVHD and relapse.Keywords
This publication has 34 references indexed in Scilit:
- HLA‐DR typing by PCR amplification with sequence‐specific primers (PCR‐SSP) in 2 hours: An alternative to serological DR typing in clinical practice including donor‐recipient matching in cadaveric transplantationTissue Antigens, 1992
- A rapid limiting dilution assay for measuring frequencies of alloreactive, interleukin-2-producing T cells in humansJournal of Immunological Methods, 1992
- Limiting dilution analysis of alloreactive T-cell status and distribution during allograft rejectionHuman Immunology, 1990
- Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for LeukemiaNew England Journal of Medicine, 1986
- A POSSIBLE PREDICTIVE TEST FOR GRAFT-VERSUS-HOST DISEASE IN BONE MARROW GRAFT RECIPIENTSTransplantation, 1986
- An in Vitro Predictive Test for Graft versus Host Disease in Patients with Genotypic HLA-Identical Bone Marrow TransplantsNew England Journal of Medicine, 1985
- IN VITRO MODEL FOR DETECTION OF ALLOREACTIVITY BETWEEN HLA-MATCHED DONOR-HOST PAIRS PRELIMINARY EVALUATION AS A PREDICTOR OF GRAFT-VERSUS-HOST DISEASETransplantation, 1982
- A Randomized Study of the Prevention of Acute Graft-versus-Host DiseaseNew England Journal of Medicine, 1982
- Antileukemic Effect of Chronic Graft-versus-Host DiseaseNew England Journal of Medicine, 1981
- Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow GraftsNew England Journal of Medicine, 1979